Damora Therapeutics, Inc.
NASDAQ:DMRABiotechnology
+$0.07 today
- Market cap
- $1.42B
- Beta
- 1.48
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$177.15
Volume 0.58M
Average 0.33M
Dividends
Damora Therapeutics, Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does Damora Therapeutics, Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Genmab A/S NASDAQ:GMAB | $31.67B | 0.00% | $0.00 | 0.00% | 0.38% |
Incyte Corporation NASDAQ:INCY | $24.66B | 0.00% | $0.00 | 0.00% | 0.00% |
Disc Medicine, Inc. NASDAQ:IRON | $3.07B | 0.00% | $0.00 | 0.00% | 0.00% |
Hemab Therapeutics Holdings, Inc. Common Stock NASDAQ:COAG | $1.91B | — | $0.00 | — | 0.00% |
uniQure N.V. NASDAQ:QURE | $1.67B | 0.00% | $0.00 | 0.00% | 0.00% |
Rigel Pharmaceuticals, Inc. NASDAQ:RIGL | $837.18M | 0.00% | $0.00 | 0.00% | 0.47% |
Geron Corporation NASDAQ:GERN | $622.98M | 0.00% | $0.00 | 0.00% | 0.00% |
Keros Therapeutics, Inc. NASDAQ:KROS | $202.13M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about DMRA's dividend, answered from reported figures.
Does DMRA stock pay dividends?
Damora Therapeutics, Inc. (DMRA) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is DMRA's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.